Asset
LX-2931
Lexicon Pharmaceuticals Inc. Common Stock
Revenue
No revenue reported in loaded filings.
Clinical trials (1)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT00847886 | phase1 | completed | 2009-02-01 | 2009-03-01 | Lexicon Pharmaceuticals | Study of LX3305 and Methotrexate in Subjects With Stable Rheumatoid Arthritis |
FDA applications (0)
This company has no applications containing this asset.